{"id":"https://openalex.org/W2123781422","doi":"https://doi.org/10.1093/jnci/88.1.44","title":"Phase II Trial of Interleukin 1 and Indomethacin in Treatment of Metastatic Melanoma","display_name":"Phase II Trial of Interleukin 1 and Indomethacin in Treatment of Metastatic Melanoma","publication_year":1996,"publication_date":"1996-01-03","ids":{"openalex":"https://openalex.org/W2123781422","doi":"https://doi.org/10.1093/jnci/88.1.44","mag":"2123781422","pmid":"https://pubmed.ncbi.nlm.nih.gov/8847725"},"language":"en","primary_location":{"id":"doi:10.1093/jnci/88.1.44","doi":"https://doi.org/10.1093/jnci/88.1.44","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/88.1.44","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI Journal of the National Cancer Institute","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113663097","display_name":"John Edward Janik","orcid":"https://orcid.org/0000-0001-9208-9660","observed_orcids":["https://orcid.org/0000-0001-9208-9660"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. E. Janik","raw_affiliation_strings":["Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center, MD 21701-4507, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center, MD 21701-4507, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111927288","display_name":"L.L. Miller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. L. Miller","raw_affiliation_strings":["Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center (NCI-FCRDC) Frederick, MD","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center (NCI-FCRDC) Frederick, MD","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D. L. Longo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. L. Longo","raw_affiliation_strings":["Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center (NCI-FCRDC) Frederick, MD","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center (NCI-FCRDC) Frederick, MD","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111531266","display_name":"G C Powers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. C. Powers","raw_affiliation_strings":["Program Resources, Inc/DynCorp, NCI-FCRDC Portland, OR","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Program Resources, Inc/DynCorp, NCI-FCRDC Portland, OR","institution_ids":[]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025100380","display_name":"Walter John Urba","orcid":"https://orcid.org/0000-0001-8414-3348","observed_orcids":["https://orcid.org/0000-0001-8414-3348"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I2801670537","display_name":"Providence Portland Medical Center","ror":"https://ror.org/015tmw922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801670537","https://openalex.org/I4210160466","https://openalex.org/I94396219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. J. Urba","raw_affiliation_strings":["Earle Chiles Research Institute, Providence Medical Center Portland, OR","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Earle Chiles Research Institute, Providence Medical Center Portland, OR","institution_ids":["https://openalex.org/I2801670537"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110312614","display_name":"William C. Kopp","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. C. Kopp","raw_affiliation_strings":["Program Resources, Inc/DynCorp, NCI-FCRDC Portland, OR","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Program Resources, Inc/DynCorp, NCI-FCRDC Portland, OR","institution_ids":[]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109813081","display_name":"Barry L. Gause","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. L. Gause","raw_affiliation_strings":["Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center (NCI-FCRDC) Frederick, MD","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center (NCI-FCRDC) Frederick, MD","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029588412","display_name":"Brendan D. Curti","orcid":"https://orcid.org/0000-0003-3948-2708","observed_orcids":["https://orcid.org/0000-0003-3948-2708"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. D. Curti","raw_affiliation_strings":["Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center (NCI-FCRDC) Frederick, MD","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center (NCI-FCRDC) Frederick, MD","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":null,"display_name":"R. G. Fenton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. G. Fenton","raw_affiliation_strings":["Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center (NCI-FCRDC) Frederick, MD","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center (NCI-FCRDC) Frederick, MD","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042240287","display_name":"Joost J. Oppenheim","orcid":"https://orcid.org/0000-0003-0271-7921","observed_orcids":["https://orcid.org/0000-0003-0271-7921"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. J. Oppenheim","raw_affiliation_strings":["Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center (NCI-FCRDC) Frederick, MD","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center (NCI-FCRDC) Frederick, MD","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035263938","display_name":"Kevin C. Conlon","orcid":"https://orcid.org/0000-0002-4118-7524","observed_orcids":["https://orcid.org/0000-0002-4118-7524"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. C. Conlon","raw_affiliation_strings":["Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center (NCI-FCRDC) Frederick, MD","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center (NCI-FCRDC) Frederick, MD","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109808800","display_name":"Jon Holmlund","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. T. Holmlund","raw_affiliation_strings":["Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center (NCI-FCRDC) Frederick, MD","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center (NCI-FCRDC) Frederick, MD","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007198397","display_name":"Mario Sznol","orcid":"https://orcid.org/0000-0003-4137-9662","observed_orcids":["https://orcid.org/0000-0003-4137-9662"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Sznol","raw_affiliation_strings":["Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center (NCI-FCRDC) Frederick, MD","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center (NCI-FCRDC) Frederick, MD","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088644322","display_name":"William Howard Sharfman","orcid":"https://orcid.org/0000-0001-7766-249X","observed_orcids":["https://orcid.org/0000-0001-7766-249X"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. H. Sharfman","raw_affiliation_strings":["Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center (NCI-FCRDC) Frederick, MD","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center (NCI-FCRDC) Frederick, MD","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109361256","display_name":"Ronald G. Steis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. G. Steis","raw_affiliation_strings":["Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center (NCI-FCRDC) Frederick, MD","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center (NCI-FCRDC) Frederick, MD","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047073824","display_name":"Stephen P. Creekmore","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. P. Creekmore","raw_affiliation_strings":["Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center (NCI-FCRDC) Frederick, MD","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center (NCI-FCRDC) Frederick, MD","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012473434","display_name":"W. Gregory Alvord","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210148012","display_name":"Data Management Services (United States)","ror":"https://ror.org/04jqjkn20","country_code":"US","type":"company","lineage":["https://openalex.org/I4210148012"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. G. Alvord","raw_affiliation_strings":["Data Management Services, Inc., Program Resources, Inc/DynCorp, NCI-FCRDC MD","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Data Management Services, Inc., Program Resources, Inc/DynCorp, NCI-FCRDC MD","institution_ids":["https://openalex.org/I4210148012"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110755242","display_name":"A. Beauchamp","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. E. Beauchamp","raw_affiliation_strings":["Frederick Memorial Hospital MD","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Frederick Memorial Hospital MD","institution_ids":[]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050048211","display_name":"John W. Smith","orcid":"https://orcid.org/0000-0002-0536-6971","observed_orcids":["https://orcid.org/0000-0002-0536-6971"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"J. W. Smith","raw_affiliation_strings":["Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center (NCI-FCRDC) Frederick, MD","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center (NCI-FCRDC) Frederick, MD","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5050048211"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"],"apc_list":{"value":5436,"currency":"USD","value_usd":5436},"apc_paid":null,"fwci":1.0468,"has_fulltext":false,"cited_by_count":30,"citation_normalized_percentile":{"value":0.79025865,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"88","issue":"1","first_page":"44","last_page":"49"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.013199999928474426,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9819999933242798},{"id":"https://openalex.org/keywords/interleukin-1-alpha","display_name":"interleukin-1 alpha","score":0.9670000076293945},{"id":"https://openalex.org/keywords/indomethacin","display_name":"indomethacin","score":1.0},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6259999871253967},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.8510000109672546},{"id":"https://openalex.org/keywords/visceral-metastasis","display_name":"visceral metastases","score":0.8740000128746033},{"id":"https://openalex.org/keywords/hla-b7","display_name":"HLA-B7","score":0.7110000252723694},{"id":"https://openalex.org/keywords/phenylephrine","display_name":"phenylephrine","score":0.8059999942779541},{"id":"https://openalex.org/keywords/hypotension","display_name":"hypotension","score":0.7710000276565552},{"id":"https://openalex.org/keywords/chills","display_name":"chills","score":0.5550000071525574},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.5260000228881836},{"id":"https://openalex.org/keywords/partial-response","display_name":"partial response","score":0.550000011920929},{"id":"https://openalex.org/keywords/treatment-side-effects","display_name":"treatment side effects","score":0.3959999978542328},{"id":"https://openalex.org/keywords/sex-hormones","display_name":"sex hormones","score":0.328000009059906}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9312776327133179},{"id":"https://openalex.org/C2778594517","wikidata":"https://www.wikidata.org/wiki/Q2260058","display_name":"Chills","level":2,"score":0.8702671527862549},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6150006651878357},{"id":"https://openalex.org/C43376680","wikidata":"https://www.wikidata.org/wiki/Q6580786","display_name":"Bolus (digestion)","level":2,"score":0.5776258707046509},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5423105955123901},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4492734670639038},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4197050929069519},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.37428224086761475},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007213","descriptor_name":"Indomethacin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007375","descriptor_name":"Interleukin-1","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012737","descriptor_name":"Sex Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015235","descriptor_name":"HLA-B Antigens","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016009","descriptor_name":"Chi-Square Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1093/jnci/88.1.44","doi":"https://doi.org/10.1093/jnci/88.1.44","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/88.1.44","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI Journal of the National Cancer Institute","raw_type":"journal-article"},{"id":"pmid:8847725","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8847725","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Cancer Institute","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W252634188","https://openalex.org/W1528323254","https://openalex.org/W1562311277","https://openalex.org/W1574330564","https://openalex.org/W1607956894","https://openalex.org/W1904436785","https://openalex.org/W1917704232","https://openalex.org/W1969454335","https://openalex.org/W1973018387","https://openalex.org/W1993706544","https://openalex.org/W1997632401","https://openalex.org/W2007737411","https://openalex.org/W2022518209","https://openalex.org/W2030530843","https://openalex.org/W2098870010","https://openalex.org/W2110489989","https://openalex.org/W2112223532","https://openalex.org/W2142782671","https://openalex.org/W2144165008","https://openalex.org/W2164322090","https://openalex.org/W2180451951","https://openalex.org/W2227468111","https://openalex.org/W2230952198","https://openalex.org/W2332648939","https://openalex.org/W2398013351"],"related_works":["https://openalex.org/W7098572322","https://openalex.org/W4252892194","https://openalex.org/W2050122785","https://openalex.org/W2157357978","https://openalex.org/W1985734566","https://openalex.org/W2489985022","https://openalex.org/W2028309712","https://openalex.org/W2112223532","https://openalex.org/W2073521151","https://openalex.org/W2037688657"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,113,275,322],"rising":[2],"incidence":[3],"of":[4,10,31,36,52,75,102,118,142,168,198,254,261,263,283,294,324,360,363,377,388,391],"malignant":[5],"melanoma":[6,334],"and":[7,42,107,130,188,225,327,349],"the":[8,32,61,72,76,90,100,192,199,207,210,236,264,389],"lack":[9],"curative":[11],"therapies":[12],"for":[13,166,221,231,252,311,407],"metastatic":[14],"disease":[15,26],"represent":[16],"a":[17,48,218,228,374,405],"therapeutic":[18],"challenge.":[19],"New":[20],"agents":[21],"effective":[22],"in":[23,44,55,278,333,373],"treating":[24],"this":[25,53],"are":[27],"needed.":[28],"PURPOSE:":[29],"Because":[30,387],"additive":[33],"antitumor":[34,73,331,394],"effects":[35],"interleukin":[37],"1":[38],"alpha":[39,121,326,365,400],"(IL-1":[40],"alpha)":[41],"indomethacin":[43,131,328],"vivo,":[45],"we":[46],"conducted":[47],"phase":[49,67],"II":[50],"trial":[51,69],"combination":[54,323],"patients":[56,88,114,156,201,212,249,266,341,378],"with":[57,202,213,267,342,356,384,393,397],"melanoma.":[58],"We":[59],"used":[60,171],"recommended":[62],"dose":[63],"determined":[64],"from":[65,182],"our":[66],"I":[68],"to":[70,154,172,206,340,370],"ascertain":[71],"activity":[74,332],"combination.":[77],"METHODS:":[78],"From":[79],"August":[80],"1,":[81],"1990,":[82],"through":[83],"July":[84],"28,":[85],"1992,":[86],"49":[87],"entered":[89],"study.":[91],"They":[92],"were":[93,148,190,309,338,353],"stratified":[94],"into":[95],"two":[96,140],"groups":[97,174],"based":[98],"on":[99,175],"presence":[101],"visceral":[103,203],"(n":[104,109],"=":[105,110,245,273,289,300,304,319],"14)":[106],"nonvisceral":[108,268,343],"35)":[111],"metastases.":[112,344],"received":[115],"7":[116],"days":[117],"both":[119],"IL-1":[120,255,325,345,364,399],"(O.1":[122],"micrograms/kg":[123],"per":[124],"day":[125],"by":[126],"intravenous":[127],"bolus)":[128],"infusion)":[129],"(50":[132],"mg":[133],"orally":[134],"every":[135],"8":[136],"hours).":[137],"At":[138],"least":[139],"cycles":[141],"therapy,":[143],"repeated":[144],"at":[145],"21-day":[146],"intervals,":[147],"planned.":[149],"Additional":[150],"treatment":[151,253,396],"was":[152,170,239,280],"given":[153,382],"those":[155],"who":[157],"had":[158],"stable":[159],"or":[160],"responding":[161,248],"lesions.":[162],"A":[163],"chi-squared":[164],"test":[165],"homogeneity":[167],"proportions":[169],"compare":[173],"several":[176],"measures.":[177],"All":[178,247,306,336],"P":[179],"values":[180],"resulted":[181],"two-sided":[183],"tests.":[184],"RESULTS:":[185],"Fever,":[186],"chills,":[187],"hypotension":[189,372,392],"among":[191],"most":[193],"common":[194],"side":[195],"effects.":[196],"None":[197],"14":[200],"metastases":[204,269],"responded":[205,302],"treatment.":[208],"Of":[209],"35":[211],"non-visceral":[214],"metastases,":[215],"three":[216,282,307],"showed":[217,227],"partial":[219],"response":[220,230,237,276,410],"6":[222],"months":[223],"each":[224],"one":[226,293],"complete":[229],"more":[232],"than":[233],"34":[234],"months;":[235],"rate":[238,277],"11%":[240],"(95%":[241],"confidence":[242],"interval":[243],"[CI]":[244],"5%-26%).":[246],"required":[250,270],"phenylephrine":[251,271,385],"alpha-induced":[256,346],"hypotension,":[257,347],"whereas":[258,292],"six":[259],"(19%)":[260],"31":[262],"nonresponding":[265],"(P":[272,303,318],".0008).":[274],"women":[279,285,308],"higher;":[281],"10":[284],"(30%;":[286],"95%":[287,298],"CI":[288,299],"11%-60%)":[290],"responded,":[291],"25":[295],"men":[296],"(4%;":[297],"0%-20%)":[301],".029).":[305],"positive":[310],"human":[312],"leukocyte":[313],"antigen":[314],"(HLA)":[315],"B7":[316,351],"expression":[317,352],".011).":[320],"CONCLUSIONS:":[321],"has":[329,367],"minimal":[330],"patients.":[335],"responses":[337],"confined":[339],"gender,":[348],"HLA":[350],"positively":[354],"associated":[355],"response.":[357],"IMPLICATIONS:":[358],"Administration":[359],"higher":[361,398],"doses":[362,401],"alone":[366,402],"been":[368],"shown":[369],"produce":[371],"large":[375],"proportion":[376],"but":[379],"can":[380],"be":[381,404],"safely":[383],"support.":[386],"association":[390],"activity,":[395],"may":[403],"strategy":[406],"attaining":[408],"better":[409],"rates.":[411]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}